Jiva Ayurveda, one of the leading Ayurveda treatment organizations, signed a memorandum of understanding with Translational Health Science and Technology Institute (THSTI), an autonomous Institute of Dept. of Biotechnology, Ministry of Science and Technology, Govt of India on 13th December 2019 with the objective of using Ayurvedic diagnostic protocols to detect Non-Alcoholic Fatty Liver Disease at an early stage, and use diet and lifestyle-based treatments to prevent the progression of the disease.
The MOU was signed by Dr Partap Chauhan, Director, Jiva Ayurveda and Prof. Gagandeep Kang, Executive Director, THSTI. Globally, millions of people suffer from NAFLD. People over the age of 40 are at a higher risk of developing the disorder, but a growing inclination to replace healthy meals with junk food, and towards unhealthy lifestyle choices has made all groups vulnerable to NAFLD.
Diet and lifestyles are the primary reasons behind NAFLD and since Ayurveda focuses on diet and lifestyle for disease treatment, the MOU will enable researchers to integrate the Ayurvedic perspective in order to develop markers for a more efficient early detection system.
Jiva Ayurveda has treated thousands of liver and gall disorders and will contribute data insights along with the Ayurvedic perspective on the disease.